vindesine has been researched along with Glial Cell Tumors in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, JH; Heo, DS; Jung, HW; Kim, CY; Kim, DG; Kim, DW; Kim, IH; Lee, SH; Paek, SH; Park, CK | 1 |
| van den Bent, MJ | 1 |
| Aldape, KD; Jochec, JL; Levin, VA; Shantz, LM | 1 |
| Alavi, JB; Bruno, LA; Weiler, CB | 1 |
| Cairncross, JG | 1 |
| Hori, S; Mori, T; Morikawa, N; Takeyama, M | 1 |
| Heimans, JJ; Hoekstra, OS; Postma, TJ; Roesdi, MF; van Groeningen, CJ; Wolbers, JG | 1 |
| DeAngelis, LM; Olson, JD; Riedel, E | 1 |
| Alavi, JB; Kirkwood, R; Marsh, JC; Schoenfeld, D; Skeel, RT; Tsung, L | 1 |
2 review(s) available for vindesine and Glial Cell Tumors
| Article | Year |
|---|---|
Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Female; Glioma; Humans; Middle Aged; Survival Rate; Temozolomide; Vindesine | 2003 |
Aggressive oligodendroglioma: a chemosensitive tumor.
Topics: Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cyclophosphamide; Glioma; Humans; Lomustine; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Salvage Therapy; Vincristine; Vindesine | 1994 |
1 trial(s) available for vindesine and Glial Cell Tumors
| Article | Year |
|---|---|
Phase II trial of spirogermanium and vindesine in malignant glioma.
Topics: Adult; Aged; Cerebellar Neoplasms; Drug Administration Schedule; Drug Evaluation; Glioma; Humans; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Random Allocation; Spiro Compounds; Vindesine | 1989 |
6 other study(ies) available for vindesine and Glial Cell Tumors
| Article | Year |
|---|---|
Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Classification; Combined Modality Therapy; Cyclophosphamide; Glioma; Humans; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy; Retrospective Studies; Survival Analysis; Vindesine; World Health Organization | 2009 |
Relationship between ornithine decarboxylase levels in anaplastic gliomas and progression-free survival in patients treated with DFMO-PCV chemotherapy.
Topics: Anaplasia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Disease Progression; Eflornithine; Glioma; Humans; Ornithine Decarboxylase; Survival Rate; Vindesine | 2007 |
Phase II evaluation of vindesine in the treatment of malignant glioma.
Topics: Adult; Aged; Brain Neoplasms; Drug Evaluation; Glioma; Humans; Middle Aged; Vinblastine; Vindesine | 1984 |
Pharmacokinetics of intra-arterially administered pirarubicin in plasma and cerebrospinal fluid of patients with glioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Doxorubicin; Female; Glioma; Humans; Infusions, Intra-Arterial; Methotrexate; Peplomycin; Vindesine | 1998 |
Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vindesine | 1998 |
Long-term outcome of low-grade oligodendroglioma and mixed glioma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Oligodendroglioma; Postoperative Complications; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Treatment Outcome; Vindesine | 2000 |